Translation

MAY 28, 2022

Halo supercharges the R&D efforts of leading enterprises across agriculture, life sciences and CPG, including Bayer, Takeda and PepsiCo. To support this mission, its Crop Science division devotes more than $2B towards its R&D budget each year. What was your R&D partnering experience with Halo?

Testimonials 52

Testimonials Science Engineering Production 52

The Pharma Data

DECEMBER 29, 2020

“The FDA clearance for our IND and the start of our Phase 2a study in patients with ESLD is a testimony to our robust preclinical research program, the unmet need in advanced liver disease, and our novel approach to organ regeneration. “LyGenesis’s progress has been simply extraordinary.

Therapies 40

Therapies FDA Trials Disease 40

Agency IQ

JUNE 29, 2023

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94

FDA 40

FDA Science Regulations Production 40

Agency IQ

JUNE 16, 2023

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94

Regulations 40

Regulations FDA Science Production 40

Agency IQ

OCTOBER 27, 2023

and Annex 1 Conference Joel Welch December 18 RAPS RAPS Webcast: FDA Forecast: What’s Next for the FDA in 2024 AgencyIQ Speakers December 21 HL7 REMS Public Call PDUFA Dates expected in November and December PDUFA dates represent the expected date of a regulatory decision by the FDA on a New Drug Application or Biologics License Application.

FDA 40

FDA Science Regulations Production 40

Agency IQ

JULY 28, 2023

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. To implement that authority, FDA published a final rule in the Federal Register on September 15, 2015 [80 FR 55237] which revised 21 CFR 1.94

FDA 40

FDA Science Biosimilars Regulations 40

The Pharma Data

MAY 15, 2021

Now I’ve shown how this is working for so many people of all age and weight… I’ve also shown you the science proving this is the answer you’ve been looking for…. You can be sure you are benefiting from a quality product that is not only backed by science, but formulated based on that exact science as well!

Production 52

Production Packaging Medical Schools Science 52